Top

Journal of Ovarian Research

Published in:

Open Access 01-12-2018 | Case report

Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy

Authors: Toshiyuki Okumura, Etuo Muronosono, Masahiko Tsubuku, Yasuhisa Terao, Satoru Takeda, Masanori Maruyama

Published in: Journal of Ovarian Research | Issue 1/2018

Abstract

Background

The mortality rate of ovarian cancer is the highest among all gynecological malignancies in Japan. Ovarian tumors are classified as benign, borderline malignant, or malignant. Anticipating the histological subtype with imaging only is often difficult because of several histological subtypes of epithelial ovarian tumors (such as serous, mucinous, endometrioid, clear cell, and Brenner tumors). In addition, the majority of mucinous tumors in the ovary are metastatic. Furthermore, mucinous tumors belong to one of the two different subclasses (i.e., intestinal and seromucinous types). Ovarian seromucinous cystic tumors of borderline malignancy are infrequent and only rarely coexist with other malignant tumors.

Case presentation

We have reported a 53-year-old Japanese woman with anaplastic carcinoma in an ovarian seromucinous cystic tumor of borderline malignancy. Her MRI and CT analysis revealed an ovarian tumor with a mural nodule, ascites, and peritoneal dissemination. Enhanced MRI revealed that the mural nodule was enhanced. Enhanced CT analysis revealed that the lymph nodes were not swollen. Intriguingly, the mural nodule crossed the cyst wall into the cavity and onto the surface. Her laboratory data revealed high serum CA 125 level. Cumulatively, these results suggested ovarian malignancy. The patient underwent hysterectomy with bilateral salpingo-oophorectomy, omentectomy, and resection of the disseminated lesions. Lymph node biopsy was omitted because of the suggestion of enhanced CT image findings and palpation during surgery. Her postoperative specimen examination determined FIGO at least stage IIIB, and accordingly, adjuvant chemotherapy was prescribed. After 3 years of the operation, the patient is presently alive without clinical tumor recurrences.

Conclusion

Imaging studies with pathognomonic findings contributed to ovarian cancer diagnosis in this case. To the best of our knowledge, this is the first study in English literature to report detailed classification of mucinous borderline malignancy, seromucinous cystic, and anaplastic carcinoma in an ovarian seromucinous cystic tumor of borderline malignancy.

Center for Cancer Control and Information Service, National Cancer Center, Japan. https://ganjoho.jp/reg_stat/statistics/dl/index.html.

Buttin BM, Herzog TJ, Powell MA, Rader JS, Mutch DG. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol. 2002;99(1):11–7. PubMed PMID: 11777503PubMed

Rice LW, Berkowitz RS, Mark SD, Yavner DL, Lage JM. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol. 1990;39(2):195–8. PubMed PMID: 2227595CrossRefPubMed

Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO Classification of Tumours of Female Reproductive Organs. In: WHO Classification of Tumours. 4. Aufl. Lyon: WHO Press; 2014.

Nakashima N, Nagasaka T, Oiwa N, Nara Y, Fukata S, Fukatsu T, Takeuchi J. Ovarian epithelial tumors of borderline malignancy in Japan. Gynecol Oncol. 1990;38(1):90–8. PubMed PMID: 2162318CrossRefPubMed

Prat J. Pathology of the ovary. Philadelphia: Saunders; 2004.

Park HK, Ruterbusch JJ, Cote ML. Recent trends in ovarian Cancer incidence and relative survival in the United States by race/ethnicity and histologic subtypes. Cancer Epidemiol Biomark Prev. 2017;26(10):1511–8. PubMed PMID: 28751475CrossRef

Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, Brewster W, Anton-Culver H, Gentry-Maharaj A, Ramus SJ, Anderson AR, Brueggmann D, Fasching PA, Gayther SA, Huntsman DG, Menon U, Ness RB, Pike MC, Risch H, Wu AH, Berchuck A, Ovarian Cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012;13(4):385–94. PubMed PMID: 22361336CrossRefPubMedPubMedCentral

Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol. 2010;202(6):514–21. PubMed PMID: 20430357CrossRefPubMedPubMedCentral

10.

Bandera EV, Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM. Obesity, weight gain, and ovarian cancer risk in African American women. Int J Cancer. 2016;139(3):593–600. PubMed PMID: 27038123CrossRefPubMedPubMedCentral

11.

Moorman PG, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Crankshaw S, Wang F, Schildkraut JM. Reproductive factors and ovarian cancer risk in African-American women. Ann Epidemiol. 2016;26(9):654–62. PubMed PMID: 27528178CrossRefPubMedPubMedCentral

12.

Mink PJ, Sherman ME, Devesa SS. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978–1998. Cancer. 2002;95(11):2380–9. PubMed PMID: 12436446CrossRefPubMed

13.

Prat J, Scully RE. Ovarian mucinous tumors with sarcoma-like mural nodules: a report of seven cases. Cancer. 1979;44(4):1332–44. PubMed PMID: 498014CrossRefPubMed

14.

Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Int J Gynecol Pathol. 1999;18(3):228.CrossRef

15.

Dubé V, Roy M, Plante M, Renaud MC, Têtu B. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int J Gynecol Pathol. 2005;24(2):138–46. Review. PubMed PMID: 15782070CrossRefPubMed

16.

Nakamura E, Sato Y, Moriguchi S, Yamashita A, Higo T, Asada Y. Ovarian Seromucinous borderline tumor and clear cell carcinoma: an unusual combination. Case Rep Obstet Gynecol. 2015;2015:690891. https://doi.org/10.1155/2015/690891. Epub 2015 May 13. PubMed PMID: 26075120; PubMed Central PMCID: PMC4444562PubMedPubMedCentralCrossRef

17.

D'Angelo E, Dadmanesh F, Pecorelli S, Prat J. Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type. Int J Gynecol Pathol. 2010;29(6):529–32. https://doi.org/10.1097/PGP.0b013e3181e4b7ae. PubMed PMID: 20881861CrossRefPubMed

18.

Yamazaki H, Matsuzawa A, Shoda T, Iguchi H, Kyushima N. Ovarian mucinous cystic tumor of borderline malignancy with a mural nodule of anaplastic spindle cell carcinoma: a case report. J Ovarian Res. 2013;6(1):86. https://doi.org/10.1186/1757-2215-6-86. PubMed PMID: 24305620; PubMed Central PMCID: PMC4176295CrossRefPubMedPubMedCentral

19.

Fox H, Langley FA. Tumors of the Ovary. Chicago: William Heinemann/Year Book; 1976.

20.

Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol. 2002;26(12):1529–41. Review. PubMed PMID: 12459620CrossRefPubMed

21.

Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer. 1988;61(2):340–8. PubMed PMID: 3334969CrossRefPubMed

22.

Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, IeM S. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol. 2012;31(4):297–303. https://doi.org/10.1097/PGP.0b013e31823f8482. PubMed PMID: 22653341; PubMed Central PMCID: PMC3501990CrossRefPubMedPubMedCentral

23.

Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, IeM S, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG, et al. N Engl J Med. 2010;363(16):1532–43. https://doi.org/10.1056/NEJMoa1008433. Epub 2010 Sep 8. PubMed PMID: 20942669; PubMed Central PMCID: PMC2976679CrossRefPubMedPubMedCentral

24.

Mesbah Ardakani N, Giardina T, Amanuel B, Stewart CJ. Molecular profiling reveals a clonal relationship between ovarian mucinous tumors and corresponding mural carcinomatous nodules. Am J Surg Pathol. 2017;41(9):1261–6. PubMed PMID: 28498287CrossRefPubMed

25.

Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–15. PubMed PMID: 21720365CrossRef

26.

Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A, Senz J, Yang W, Prigge ES, Reuschenbach M, Doeberitz MV, Gilks BC, Huntsman DG, Bakkum-Gamez J, McAlpine JN, Anglesio MS. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. BMC Cancer. 2015;15:415. PubMed PMID: 25986173CrossRefPubMedPubMedCentral

27.

Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol. 2006;19(1):97–105. PubMed PMID: 16294196CrossRefPubMed

28.

Matias-Guiu X, Aranda I, Prat J. Immunohistochemical study of sarcoma-like mural nodules in a mucinous cystadenocarcinoma of the ovary. Virchows Arch A Pathol Anat Histopathol. 1991;419(2):89–92. PubMed PMID: 1714661CrossRefPubMed

29.

Provenza C, Young RH, Prat J. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules. Am J Surg Pathol. 2008;32(3):383–9. PubMed PMID: 18300813CrossRefPubMed

30.

Hillesheim PB, Farghaly H. Anaplastic spindle cell carcinoma, arising in a background of an ovarian mucinous cystic tumor: a case report with clinical follow up, review of the literature. Int J Clin Exp Pathol. 2010;3(8):808–11. Review. PubMed PMID: 21151395; PubMed Central PMCID: PMC2993232PubMedPubMedCentral

Title: Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy
Authors: Toshiyuki Okumura
Etuo Muronosono
Masahiko Tsubuku
Yasuhisa Terao
Satoru Takeda
Masanori Maruyama
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Journal of Ovarian Research / Issue 1/2018
Electronic ISSN: 1757-2215
DOI: https://doi.org/10.1186/s13048-018-0449-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy

Abstract

Background

Case presentation

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

Mass spectrometry-based proteomics techniques and their application in ovarian cancer research

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells

Circular RNAs: biogenesis, expression and their potential roles in reproduction

Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence

Comparison of stage III mucinous and serous ovarian cancer: a case-control study

Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review